Department of Plastic & Reconstructive Surgery, School of Medicine, Shanghai Ninth People's Hospital, Shanghai Jiao Tong University, 639 Zhizaoju Road, Shanghai, 200011, China.
STipe Therapeutics, Aarhus, Denmark.
J Transl Med. 2023 Mar 2;21(1):164. doi: 10.1186/s12967-023-04018-5.
Fibrosis, a process caused by excessive deposition of extracellular matrix (ECM), is a common cause and outcome of organ failure and even death. Researchers have made many efforts to understand the mechanism of fibrogenesis and to develop therapeutic strategies; yet, the outcome remains unsatisfactory. In recent years, advances in epigenetics, including chromatin remodeling, histone modification, DNA methylation, and noncoding RNA (ncRNA), have provided more insights into the fibrotic process and have suggested the possibility of novel therapy for organ fibrosis. In this review, we summarize the current research on the epigenetic mechanisms involved in organ fibrosis and their possible clinical applications.
纤维化是一种由细胞外基质(ECM)过度沉积引起的过程,是器官衰竭甚至死亡的常见原因和结果。研究人员为了理解纤维化的发生机制并开发治疗策略付出了很多努力,但结果仍不尽人意。近年来,表观遗传学的进展,包括染色质重塑、组蛋白修饰、DNA 甲基化和非编码 RNA(ncRNA),为纤维化过程提供了更多的见解,并为器官纤维化的新疗法提供了可能。在这篇综述中,我们总结了目前关于器官纤维化中涉及的表观遗传机制的研究及其可能的临床应用。